IN2014DN09774A - - Google Patents

Info

Publication number
IN2014DN09774A
IN2014DN09774A IN9774DEN2014A IN2014DN09774A IN 2014DN09774 A IN2014DN09774 A IN 2014DN09774A IN 9774DEN2014 A IN9774DEN2014 A IN 9774DEN2014A IN 2014DN09774 A IN2014DN09774 A IN 2014DN09774A
Authority
IN
India
Prior art keywords
synthesis
activated
improved
disclosed embodiments
intermediates
Prior art date
Application number
Other languages
English (en)
Inventor
Kelly Kraft
John Freeman
Paul Serwinski
Vinnie Pavia
Otto Phantsiel
Navneet Kaur
Original Assignee
Mannkind Corp
Kelly Kraft
John Freeman
Serwin Ski Paul
Vinnie Pavia
Otto Phantsiel
Navneet Kaur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mannkind Corp, Kelly Kraft, John Freeman, Serwin Ski Paul, Vinnie Pavia, Otto Phantsiel, Navneet Kaur filed Critical Mannkind Corp
Publication of IN2014DN09774A publication Critical patent/IN2014DN09774A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/12Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/39Preparation of carboxylic acid esters by oxidation of groups which are precursors for the acid moiety of the ester

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN9774DEN2014 2012-04-27 2013-03-15 IN2014DN09774A (enEXAMPLES)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261639536P 2012-04-27 2012-04-27
PCT/US2013/032162 WO2013162764A1 (en) 2012-04-27 2013-03-15 Methods for the synthesis of ethylfumarates and their use as intermediates

Publications (1)

Publication Number Publication Date
IN2014DN09774A true IN2014DN09774A (enEXAMPLES) 2015-07-31

Family

ID=49477848

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9774DEN2014 IN2014DN09774A (enEXAMPLES) 2012-04-27 2013-03-15

Country Status (16)

Country Link
US (6) US9193691B2 (enEXAMPLES)
EP (1) EP2841422B1 (enEXAMPLES)
JP (1) JP6241682B2 (enEXAMPLES)
KR (1) KR20150023315A (enEXAMPLES)
CN (2) CN104797563B (enEXAMPLES)
AU (2) AU2013252901B2 (enEXAMPLES)
BR (1) BR112014026809A2 (enEXAMPLES)
CA (1) CA2871126C (enEXAMPLES)
HK (1) HK1207382A1 (enEXAMPLES)
IL (1) IL235247A0 (enEXAMPLES)
IN (1) IN2014DN09774A (enEXAMPLES)
MX (1) MX361470B (enEXAMPLES)
RU (1) RU2014143116A (enEXAMPLES)
SG (1) SG11201406970QA (enEXAMPLES)
WO (1) WO2013162764A1 (enEXAMPLES)
ZA (1) ZA201408429B (enEXAMPLES)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
JP4681231B2 (ja) 2002-03-20 2011-05-11 マンカインド コーポレイション 吸入装置
DE602005024413D1 (de) 2004-08-20 2010-12-09 Mannkind Corp Katalyse der diketopiperazinsynthese
ES2543007T3 (es) 2004-08-23 2015-08-13 Mannkind Corporation Micropartículas que comprenden sales de dicetopiperazina para la administración de fármacos
ES2640282T3 (es) 2005-09-14 2017-11-02 Mannkind Corporation Método de formulación de fármacos basado en el aumento de la afinidad de superficies de micropartículas cristalinas para agentes activos
EP1986679B1 (en) 2006-02-22 2017-10-25 MannKind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
CN106039494B (zh) 2008-06-13 2019-12-24 曼金德公司 干粉吸入器和用于药物输送的系统
CN102065942B (zh) 2008-06-20 2013-12-11 曼金德公司 用于对吸入工作进行实时描绘的交互式设备和方法
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
MX2011009512A (es) 2009-03-11 2011-11-29 Mannkind Corp Aparato, sistema y metodo para medir la resistencia de un inhalador.
MY157166A (en) 2009-06-12 2016-05-13 Mankind Corp Diketopiperazine microparticles with defined specific surface areas
US9016147B2 (en) 2009-11-03 2015-04-28 Mannkind Corporation Apparatus and method for simulating inhalation efforts
AU2011271097B2 (en) 2010-06-21 2014-11-27 Mannkind Corporation Dry powder drug delivery system and methods
SG194034A1 (en) 2011-04-01 2013-11-29 Mannkind Corp Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
KR20140095483A (ko) 2011-10-24 2014-08-01 맨카인드 코포레이션 통증을 치료하기 위한 방법 및 조성물
IN2014DN09774A (enEXAMPLES) * 2012-04-27 2015-07-31 Mannkind Corp
CA2878457C (en) 2012-07-12 2021-01-19 Mannkind Corporation Dry powder drug delivery systems and methods
EP2911690A1 (en) 2012-10-26 2015-09-02 MannKind Corporation Inhalable influenza vaccine compositions and methods
SG10201708090TA (en) 2013-03-15 2017-11-29 Mannkind Corp Microcrystalline diketopiperazine compositions and methods
CA2918369C (en) 2013-07-18 2021-06-29 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
WO2015021064A1 (en) 2013-08-05 2015-02-12 Mannkind Corporation Insufflation apparatus and methods
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
CN117646042B (zh) * 2023-11-13 2025-04-11 浙江工业大学 一种富马酸单酯的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3407203A (en) 1965-03-22 1968-10-22 Union Carbide Corp Novel process for the preparation of diketopiperazines
US5352461A (en) * 1992-03-11 1994-10-04 Pharmaceutical Discovery Corporation Self assembling diketopiperazine drug delivery system
DE10019879A1 (de) 2000-04-20 2001-10-25 Degussa Verfahren zur Herstellung von 2,5-Diketopiperazinen, neue 2,5-Diketopiperazine und deren Verwendung
DE602005024413D1 (de) 2004-08-20 2010-12-09 Mannkind Corp Katalyse der diketopiperazinsynthese
ES2543007T3 (es) * 2004-08-23 2015-08-13 Mannkind Corporation Micropartículas que comprenden sales de dicetopiperazina para la administración de fármacos
EP1986679B1 (en) * 2006-02-22 2017-10-25 MannKind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
CA2748490C (en) * 2008-12-29 2016-10-04 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US8314106B2 (en) * 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
EP2427430B1 (en) * 2009-05-04 2014-09-10 The Royal Institution for the Advancement of Learning/McGill University 5-oxo-ete receptor antagonist compounds
CN101851213A (zh) 2010-06-21 2010-10-06 于清 3,6-双(4-双反丁烯二酰基氨丁基)-2,5-二酮哌嗪及其盐取代物的合成方法
WO2012109256A2 (en) 2011-02-10 2012-08-16 Mannkind, Corp Formation of n-protected bis-3,6-(4-aminoalkyl) -2,5,diketopiperazine
IN2014DN09774A (enEXAMPLES) * 2012-04-27 2015-07-31 Mannkind Corp

Also Published As

Publication number Publication date
MX361470B (es) 2018-12-06
US20190010131A1 (en) 2019-01-10
JP2015519321A (ja) 2015-07-09
CN104797563B (zh) 2017-12-15
AU2018201397A1 (en) 2018-03-22
US20230057608A1 (en) 2023-02-23
US10071969B2 (en) 2018-09-11
BR112014026809A2 (pt) 2017-06-27
US20160159753A1 (en) 2016-06-09
SG11201406970QA (en) 2014-11-27
US20250109109A1 (en) 2025-04-03
MX2014013075A (es) 2015-08-14
EP2841422B1 (en) 2019-08-28
US12202807B2 (en) 2025-01-21
CA2871126A1 (en) 2013-10-31
US20130289278A1 (en) 2013-10-31
AU2013252901A1 (en) 2014-11-06
AU2018201397B2 (en) 2019-05-02
CN104797563A (zh) 2015-07-22
CN107879938A (zh) 2018-04-06
HK1207382A1 (en) 2016-01-29
US9193691B2 (en) 2015-11-24
IL235247A0 (en) 2014-12-31
WO2013162764A1 (en) 2013-10-31
ZA201408429B (en) 2021-05-26
US10858325B2 (en) 2020-12-08
KR20150023315A (ko) 2015-03-05
AU2013252901B2 (en) 2017-11-30
CA2871126C (en) 2020-07-14
RU2014143116A (ru) 2016-06-20
US11479535B2 (en) 2022-10-25
EP2841422A1 (en) 2015-03-04
US20210114994A1 (en) 2021-04-22
EP2841422A4 (en) 2016-04-13
JP6241682B2 (ja) 2017-12-06

Similar Documents

Publication Publication Date Title
IN2014DN09774A (enEXAMPLES)
MX2011009369A (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
EP2526199A4 (en) PROCESS FOR PRODUCING ZINC FINGERUCLEASES WITH CHANGED EFFECT
WO2012050975A3 (en) Novel circular mammalian rna molecules and uses thereof
MY168935A (en) Synthesis of heterocyclic compounds
ATE502939T1 (de) Disubstituierte alkyl-8-azabicycloä3.2.1üoktan- verbindungen als mu-opioid-rezeptorantagonisten
CL2009000650A1 (es) Compuestos derivados de amino-pirazina, inhibidores de cinasa-pi 3; composicion farmaceutica; y uso para el tratamiento de condiciones inflamatorias o alérgicas, tales como enfermedades respiratorias, artritis reumatoide, colitis ulcerativa, entre otras
EP2556042A4 (en) INTEGRATED METHOD FOR THE SIMULTANEOUS PREPARATION OF TRANS-1-CHLORO-3,3,3-TRIFLUORPROPES AND TRANS-1,3,3,3-TETRAFLUORPROPES
TNSN08513A1 (en) Carbonylated (aza) cyclohexanes as dopamine d3 receptor ligands
PH12014501179B1 (en) New bicyclic dihydroisoquinoline-1-one derivatives
EP2686354A4 (en) SYNTHESIS 2,3,3,3-TETRAFLUORPROPHIC FLUOROPOLYMERS
PT2379216T (pt) Reator e processo para a produção de fosgénio
UA94639C2 (ru) Трициклические соединения и их применение как модуляторов глюкокортикоидного рецептора
MA33537B1 (fr) Anticorps anti-cdcp1 humanisés
MX350211B (es) Proceso para la preparacion del etil-ester del acido n- (4-ciclohexil-3-trifluoro-metil-benciloxi) -acetimidico.
MX2011008825A (es) 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3.
MX2012007341A (es) Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso.
EA201391618A1 (ru) Комбинация, содержащая умеклидиний и кортикостероид
CL2011001427A1 (es) Compuestos derivados de 4-azetidinil-1-heteroaril-ciclohexanol; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como epoc, aterosclerosis, artritis reumatoide, entre otras.
EP2691396A4 (en) ENOPEPTINES, USES THEREOF AND SYNTHESIS METHOD THEREFOR
MX2011008662A (es) 2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3.
MX2011009338A (es) 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3.
PH12016502534A1 (en) Azaquinazoline carboxamide derivatives
WO2011129636A3 (ko) 초급속연소법을 이용한 나노전극재료 합성방법 및 그 방법으로 합성된 나노전극재료
GB201103256D0 (en) Solid support and method of recovering biological material therefrom